HLA A,B,C,DR1,3,4,5, DQ Intermediate Resolution
Use
HLA antigens may be correlated with certain disease states or other clinical conditions. Indicate in clinical information which antigen(s) is of interest. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration. The test may require additional confirmatory or reflex tests, extending the result turnaround time. Specimen handling and storage are critical to avoid rejection.
Methodology
NGS (Targeted)
Biomarkers
No genes
Gene
LOINC Codes
- 13298-5 - HLA-A
- 13299-3 - HLA-B
- 42664-3 - HLA-Cw
- 57298-2 - HLA-DRB1
- 59022-4 - HLA-DRB3
- 59021-6 - HLA-DRB4
- 59020-8 - HLA-DRB5
- 53938-7 - HLA-DQB1
Result Turnaround Time
6-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain specimen at room temperature; protect from extreme heat or cold. Do not freeze.
Causes for Rejection
Hemolyzed specimen; clotted specimen; wrong specimen container
Other tests from different labs that may be relevant